Multi-criteria decision analysis (MCDA) is a field that provides solution to the complex issue where multiple conflicting criteria occur for determination of the alternatives. Fuzzy logic is a process, which enables the expert defining and analyzing the environment under vague conditions. In this study the fuzzy based MCDA model is proposed for the analytical evaluation of the asthma medical devices. Asthma is a respiratory disease that affects the lungs. When the lungs are unable to inhale air properly, it becomes inflamed and swollen. The inflammation makes it difficult to breathe in air into the lungs and when air is not properly inhaled into the lungs, it could lead to death. Dust, tobacco smoke, old buildings/paintings, stress, anxiety, obesity and low weight, pollen grains, genetics, occupational chemicals are the main causes of the asthma. These causes needed to properly managed else it may cause the asthma attack. The attack of the asthma arises when any of the causes of asthma triggers the lungs that can make the airways become swollen and inflamed. Coughing, wheezing, tightness of chest and inability to breathe properly are the main symptoms of asthma. It can be managed and treated with the appropriate medical devices. These devices are inhalers and they designed to give medication into the lungs through inhalation to allow the release of the lungs or expansion of the lungs to allow the flow of air properly. Inhalers are portable devices that are used to administer drugs to asthma patients. The drugs are bronchodilators and anti-inflammatory which release the lungs when they are inhaled for allow the air flow. 7 different inhalers are analyzed from the 4 types of inhalers which include: Soft mist inhaler, Respimat inhaler, Dry powder inhaler and Nebulizers. These inhalers were evaluated and compared using fuzzy Preference Ranking Organization Method for Enrichment of Evaluations (PROMETHEE), which is a hybrid multi-criteria decision making technique. The parameters are selected as side effects, specificity, efficiency, cost, practicability, treatment duration, limitation, advantages and disadvantages. Based on the selected parameters accuhaler dry powder inhaler ranked as the best alternative with 0,2078 net flow value, soft mist inhaler ranked as the second with net flow value of 0,1943 and followed with Jet Nebulizer with 0,1912 net flow value.

1.
O.
Feynman
and
S.
Sinha
,
Ann. Glob. Health
85
,
1
(
2019
).
2.
X.
Fu
,
Y.
Li
,
Y.
Meng
,
Q.
Yuan
,
Z.
Zhang
,
H.
Wen
, and
Y.
Sun
,
Environ. Res.
194
,
1
(
2021
).
3.
T.
Ferkol
and
D.
Schraufnagel
,
Ann. Am. Thorac. Soc.
11
,
404
406
(
2014
).
4.
C. L.
Christian
,
L. L. H.
Ilean
,
M.
Mariana
,
R. C.
William
, and
T. P.
Jose
,
Radiology Case Reports
16
,
254
257
(
2021
).
5.
O. S.
Usmani
,
Ther Clin Risk Manag
15
,
461
(
2019
).
6.
S.
Kooij
,
A.
Astefanei
,
G. L.
Corthals
, and
D.
Bonn
,
Scientific reports
9
,
1
8
(
2019
).
7.
F. S.
Yildirim
,
M.
Sayan
,
T.
Sanlidag
,
B.
Uzun
,
D. U.
Ozsahin
, and
I.
Ozsahin
,
J. Healthc. Eng.
1
,
1
(
2021
).
8.
J.
Brans
and
P.
Vincke
,
J. Manag. Sci.
31
,
647
656
(
1985
).
This content is only available via PDF.
You do not currently have access to this content.